reviewNature BiotechnologyJul 1, 2012Closed access

Combinatorial drug therapy for cancer in the post-genomic era

BABissan Al‐Lazikani UBUdai Banerji PWPaul Workman

Cancer Research UK · Institute of Cancer Research · +1 more institution

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,085

total citations

FWCI: 24.52
Percentile: 100%
References: 173

Citations per year

Authors

3

BA
Bissan Al‐LazikaniCorresponding
Cancer Research UK, Institute of Cancer Research
UB
Udai Banerji
Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Cancer Research UK
PW
Paul Workman
Cancer Research UK, Institute of Cancer Research

Topics & keywords

Topics

Keywords

Personalized medicine
Drug resistance
Precision medicine
Cancer
Targeted therapy
Limiting
Computational biology
Genomics

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.

Funding